Loading...

EVH - Evolent Health, Inc.

Analyst Coverage Initiated Signal for 03-01-2024
Analyst Coverage Initiated: EVH rating Outperform by Oppenheimer
Price Target: $45


Loading Chart EVH

Stock Signal Information


Signal

Analyst Coverage Initiated: EVH rating Outperform by Oppenheimer
Price Target: $45
Report Date: 03-01-2024
Symbol: EVH - Evolent Health, Inc.
Sector: Healthcare
Industry: Health Information Services
Analyst Coverage Initiated: EVH rating Outperform by Oppenheimer
Price Target: $45

  EVH Technical Analysis

Company Contact

Evolent Health, Inc. (EVH)
800 N Glebe Rd Ste 500
Arlington, VIRGINIA 22203
Phone: 15713896000
Website: http://www.evolenthealth.com
CEO: Mr. Frank Williams

EVH, Evolent Health, Inc.

EVH Evolent Health, Inc. Logo Image

NYSE, New York Stock Exchange


Company Profile

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates through two segments, Services and True Health. The Services segment provides value-based care services that include Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows and engages patients; population health performance that delivers patient-centric cost effective care; delivery network alignments; and integrated cost and revenue management solutions. This segment also offers specialty care management solutions that support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation, and specific market dynamics; and comprehensive health plan administrative services that helps providers assemble the complete infrastructure required to operate, manage, and capitalize on a variety of financial and administrative management services. The True Health segment operates a commercial health plan for small and large businesses in New Mexico. The company was founded in 2011 and is headquartered in Arlington, Virginia.